The Kelly lab is interested in the mechanisms governing mitochondrial function and fuel metabolism in the developing and diseased heart. The long-term goal of our studies is to identify novel targets for novel metabolic modulator therapy aimed at heart failure in diabetic and non-diabetic patients.